Is thrombolysis for intermediate-risk pulmonary embolism beneficial? The case of emeritus professor Crow

Internal and Emergency Medicine

Volumn 4, Issue 4, 2009, Pages 339-341

  Squizzato, Alessandro ^a   Moja, Lorenzo ^b   Gensini, Gian Franco ^c   Gusinu, Roberto ^c   Conti, Andrea A ^d  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350620554     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-009-0267-y     Document Type: Article

References (8)

1. Oxman AD, Chalmers I, Liberati A (2004) A field guide to experts. BMJ 329:1460-1463.
2. Kearon C, Kahn SR, Agnelli G et al (2008) Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edn). Chest 133:454S-545S.
3. Torbicki A, Perrier A, Konstantinides S et al (2008) Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 29:2276-2315.
4. Dong B, Jirong Y, Liu G et al (2006) Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev CD004437.
5. Jerjes-Sanchez C, Ramirez-Rivera A, de Lourdes Garcia M et al (1995) Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis 2:227-229.
6. Meyer G PEITHO Pulmonary embolism thrombolysis study-protocol. Available at: http://clinicaltrials.gov/ct2/show/NCT00639743?term=pulmonary+embolism+tenecteplase&rank=3.
7. Konstantinides S (2008) Clinical practice. Acute pulmonary embolism. N Engl J Med 359:2804-2813.
8. Conti AA, Gensini GF (2008) Doctor-patient communication: a historical overview. Minerva Med 99:411-415.